Vigorito C, Giordano A, De Caprio L, Vitale D, Ferrara N, Canonico V, Silvestri P, Casaburi E, Ferraro P, Rengo F
G Ital Cardiol. 1986 Dec;16(12):1032-6.
We evaluated the protective effect of Diltiazem from pacing-induced myocardial ischemia in 9 patients (pts) with coronary heart disease (CAD) and stable effort angina by studying the changes in systemic and coronary hemodynamics during pacing. Hemodynamic parameters were evaluated at baseline and at peak pacing before and after Diltiazem, 25 mg i.v. Diltiazem prevented angina in 6 of 7 pts who presented angina in the control pacing. This beneficial effect was accompanied at peak pacing rate by a significant fall in ST depression, arterial pressure, rate-pressure product and left ventricular (LV) end-diastolic pressure, while no significant changes were observed in LV dp/dt max, coronary blood flow and coronary vascular resistance. Therefore, Diltiazem exerts a protective effect from pacing-induced myocardial ischemia in pts with CAD and stable effort angina, without impairing LV function. This beneficial effect is due to a reduction in myocardial metabolic requirements, rather than to an improvement of blood supply to the ischemic myocardium.
我们通过研究起搏期间全身和冠状动脉血流动力学的变化,评估了地尔硫䓬对9例冠心病(CAD)和稳定劳力型心绞痛患者起搏诱导的心肌缺血的保护作用。在基线以及静脉注射25 mg地尔硫䓬前后的起搏峰值时评估血流动力学参数。地尔硫䓬预防了7例在对照起搏时出现心绞痛的患者中的6例发生心绞痛。在起搏峰值速率时,这种有益作用伴随着ST段压低、动脉压、心率-血压乘积和左心室(LV)舒张末期压力的显著下降,而LV dp/dt max、冠状动脉血流量和冠状动脉血管阻力未观察到显著变化。因此,地尔硫䓬对CAD和稳定劳力型心绞痛患者的起搏诱导的心肌缺血具有保护作用,而不损害左心室功能。这种有益作用是由于心肌代谢需求的降低,而不是由于缺血心肌血液供应的改善。